Literature DB >> 24115173

Concerning the structure of apoE.

Carl Frieden1, Kanchan Garai.   

Abstract

Apolipoprotein E (apoE), first described in 1973, is a truly fascinating protein. While studies initially focused on its role in cholesterol and lipid metabolism, one apoE isoform (apoE4) is a major risk factor for development of late onset Alzheimer's disease. Yet the difference between apoE3, the common form, and apoE4 is a single amino acid of the 299 in this 34 kDa protein. Structure determination of the two domain full length apoE3 protein was only accomplished in 2011 and supports the notion that mutations in the N-terminal domain can be propagated through the structure to the C-terminal domain. Understanding the structural differences between apoE3 and apoE4 is critical for finding ways to modulate the deleterious effect of apoE4.
© 2013 The Protein Society.

Entities:  

Keywords:  Alzheimer's disease; apoE isoforms; domain interactions; salt bridges; structural changes

Mesh:

Substances:

Year:  2013        PMID: 24115173      PMCID: PMC3843636          DOI: 10.1002/pro.2379

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  41 in total

1.  Alzheimer disease: multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Ann Neurol       Date:  2009-06       Impact factor: 10.422

Review 2.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

3.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

4.  Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.

Authors:  Leon M Tai; Tina Bilousova; Lisa Jungbauer; Stephen K Roeske; Katherine L Youmans; Chunjiang Yu; Wayne W Poon; Lindsey B Cornwell; Carol A Miller; Harry V Vinters; Linda J Van Eldik; David W Fardo; Steve Estus; Guojun Bu; Karen Hoppens Gylys; Mary Jo Ladu
Journal:  J Biol Chem       Date:  2013-01-04       Impact factor: 5.157

5.  Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid.

Authors:  M A Perugini; P Schuck; G J Howlett
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

6.  Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.

Authors:  Hung-Kai Chen; Zhaoping Liu; Anke Meyer-Franke; Jens Brodbeck; Rene D Miranda; James G McGuire; Michael A Pleiss; Zhong-Sheng Ji; Maureen E Balestra; David W Walker; Qin Xu; Dah-eun Jeong; Madhu S Budamagunta; John C Voss; Stephen B Freedman; Karl H Weisgraber; Yadong Huang; Robert W Mahley
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

7.  Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.

Authors:  T Wisniewski; A Golabek; E Matsubara; J Ghiso; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity.

Authors:  Arun Sivashanmugam; Jianjun Wang
Journal:  J Biol Chem       Date:  2009-03-23       Impact factor: 5.157

10.  Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis.

Authors:  Jungsu Kim; Adam E M Eltorai; Hong Jiang; Fan Liao; Philip B Verghese; Jaekwang Kim; Floy R Stewart; Jacob M Basak; David M Holtzman
Journal:  J Exp Med       Date:  2012-11-05       Impact factor: 14.307

View more
  18 in total

Review 1.  The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts.

Authors:  Amy L Heffernan; Cameron Chidgey; Po Peng; Colin L Masters; Blaine R Roberts
Journal:  J Mol Neurosci       Date:  2016-08-06       Impact factor: 3.444

2.  Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.

Authors:  Palaniappan S Chetty; Leland Mayne; Sissel Lund-Katz; S Walter Englander; Michael C Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

3.  Molecular Mechanisms of the R61T Mutation in Apolipoprotein E4: A Dynamic Rescue.

Authors:  Benfeard Williams; Marino Convertino; Jhuma Das; Nikolay V Dokholyan
Journal:  Biophys J       Date:  2017-09-12       Impact factor: 4.033

4.  ApoE: the role of conserved residues in defining function.

Authors:  Carl Frieden
Journal:  Protein Sci       Date:  2014-12-09       Impact factor: 6.725

Review 5.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

6.  ApoE: In Vitro Studies of a Small Molecule Effector.

Authors:  Tridib Mondal; Hanliu Wang; Gregory T DeKoster; Berevan Baban; Michael L Gross; Carl Frieden
Journal:  Biochemistry       Date:  2016-04-27       Impact factor: 3.162

7.  Fluorescence study of domain structure and lipid interaction of human apolipoproteins E3 and E4.

Authors:  Chiharu Mizuguchi; Mami Hata; Padmaja Dhanasekaran; Margaret Nickel; Keiichiro Okuhira; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochim Biophys Acta       Date:  2014-12

Review 8.  Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.

Authors:  Yu Yamazaki; Na Zhao; Thomas R Caulfield; Chia-Chen Liu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2019-07-31       Impact factor: 44.711

9.  Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E.

Authors:  David Nguyen; Padmaja Dhanasekaran; Margaret Nickel; Chiharu Mizuguchi; Mayu Watanabe; Hiroyuki Saito; Michael C Phillips; Sissel Lund-Katz
Journal:  Biochemistry       Date:  2014-06-24       Impact factor: 3.162

10.  ApoE4-specific Misfolded Intermediate Identified by Molecular Dynamics Simulations.

Authors:  Benfeard Williams; Marino Convertino; Jhuma Das; Nikolay V Dokholyan
Journal:  PLoS Comput Biol       Date:  2015-10-27       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.